Pharma industry expects to report 7-9 per cent revenue growth in FY23
The CRISIL estimates are based on a study of 184 drug makers accounting for 55 per cent of the 3.4 lakh crore-a-year sector revenue23-08-2022
Pharma industry expects to report 7-9 per cent revenue growth in FY23
The CRISIL estimates are based on a study of 184 drug makers accounting for 55 per cent of the 3.4 lakh crore-a-year sector revenueCRISIL downgrades Andhra Pradesh Capital Region's Rs 2,000 cr bonds
The ratings agency CRISIL has downgraded the Andhra Pradesh Capital Region Development Authority's bonds worth Rs 2,000 crore, to 'CRISIL A-(CE)' from 'CRISIL A+(CE)'New digital lending norms to raise operational intensity, compliance costs for lenders: CRISIL
Norms to impact the buy now, pay later' services and prepaid instrumentsCRISIL LTD. - 500092 - Business Responsibility and Sustainability Reporting (BRSR)
Please find enclosed herewith a copy of the Business Responsibility & Sustainability Report (BRSR) of the Company for the financial year ended December 31, 2021. This report should be read together with the ESG Report and ESG Databook. The BRSR report is also being uploaded on the website of the Company at https://www.crisil.com/en/home/investors/financial-information/annual-report-info-2021/sustainability-report.html Kindly take the same on record.CRISIL LTD. - 500092 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an analyst meeting is scheduled as per the attachmentCRISIL LTD. - 500092 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an analyst meeting is scheduled as per the attachment.CRISIL LTD. - 500092 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Scheme of Amalgamation ('Scheme') of two wholly owned subsidiary companies viz., CRISIL Risk and Infrastructure Solutions Limited ('CRISIL Risk') and Pragmatix Services Private Limited ('Pragmatix') with CRISIL Limited ('the Company')CRISIL LTD. - 500092 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an analyst meeting is scheduled as per the attachment.CRISIL LTD. - 500092 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an analyst meeting is scheduled as per the attachment.CRISIL LTD. - 500092 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an analyst meeting is scheduled as per the attachment.